LublinFDReingoldSCCohenJAet al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83: 278–286.
2.
BstehGFeigeJEhlinget al. Discontinuation of disease-modifying therapies in multiple sclerosis: Clinical outcome and prognostic factors. Mult Scler2017; 23: 1241–1248.
3.
WarnkeCGrafJHartungHP.Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod. Mult Scler2017; 23: 1176–1178.